Data collection in clinical trials is becoming complex, with a huge number of variables that need to be recorded, verified, and analyzed to effectively measure clinical outcomes. In this study, we used data warehouse (DW) concepts to achieve this goal. A DW was developed to accommodate data from a large clinical trial, including all the characteristics collected. We present the results related to baseline variables with the following objectives: developing a data quality (DQ) control strategy and improving outcome analysis according to the clinical trial primary end points.

Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes / Zaccaria, Gian Maria; Ferrero, Simone; Rosati, Samanta; Ghislieri, Marco; Genuardi, Elisa; Evangelista, Andrea; Sandrone, Rebecca; Castagneri, Cristina; Barbero, Daniela; Lo Schirico, Mariella; Arcaini, Luca; Molinari, Anna Lia; Ballerini, Filippo; Ferreri, Andres; Omedè, Paola; Zamò, Alberto; Balestra, Gabriella; Boccadoro, Mario; Cortelazzo, Sergio; Ladetto, Marco. - In: JCO CLINICAL CANCER INFORMATICS. - ISSN 2473-4276. - ELETTRONICO. - 3:3(2019), pp. 1-15-15. [10.1200/CCI.19.00049]

Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes

Rosati, Samanta;Ghislieri, Marco;Castagneri, Cristina;Balestra, Gabriella;
2019

Abstract

Data collection in clinical trials is becoming complex, with a huge number of variables that need to be recorded, verified, and analyzed to effectively measure clinical outcomes. In this study, we used data warehouse (DW) concepts to achieve this goal. A DW was developed to accommodate data from a large clinical trial, including all the characteristics collected. We present the results related to baseline variables with the following objectives: developing a data quality (DQ) control strategy and improving outcome analysis according to the clinical trial primary end points.
File in questo prodotto:
File Dimensione Formato  
CCI.19.00049.pdf

embargo fino al 21/04/2020

Tipologia: 2a Post-print versione editoriale / Version of Record
Licenza: PUBBLICO - Tutti i diritti riservati
Dimensione 1.15 MB
Formato Adobe PDF
1.15 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11583/2764439
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo